Mayako Yamazaki

549 total citations
28 papers, 470 citations indexed

About

Mayako Yamazaki is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Mayako Yamazaki has authored 28 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 8 papers in Cognitive Neuroscience. Recurrent topics in Mayako Yamazaki's work include Neuroscience and Neuropharmacology Research (9 papers), Cholinesterase and Neurodegenerative Diseases (7 papers) and Memory and Neural Mechanisms (6 papers). Mayako Yamazaki is often cited by papers focused on Neuroscience and Neuropharmacology Research (9 papers), Cholinesterase and Neurodegenerative Diseases (7 papers) and Memory and Neural Mechanisms (6 papers). Mayako Yamazaki collaborates with scholars based in Japan and Sweden. Mayako Yamazaki's co-authors include Isamu Yamaguchi, Naoki Matsuoka, Noriaki Maeda, Junko Yarimizu, Nobuya Matsuoka, Katsuya Harada, Y. Ohkubo, Masaru Okabe, Noriyuki Yamamoto and Keni Ni and has published in prestigious journals such as PLoS ONE, Brain Research and Neuroscience.

In The Last Decade

Mayako Yamazaki

28 papers receiving 457 citations

Peers

Countries citing papers authored by Mayako Yamazaki

Since Specialization

Citations

This map shows the geographic impact of Mayako Yamazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayako Yamazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayako Yamazaki more than expected).

Fields of papers citing papers by Mayako Yamazaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayako Yamazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayako Yamazaki. The network helps show where Mayako Yamazaki may publish in the future.

Co-authorship network of co-authors of Mayako Yamazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Mayako Yamazaki. A scholar is included among the top collaborators of Mayako Yamazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mayako Yamazaki. Mayako Yamazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of (+)-bicuculline, a GABAa receptor antagonist, on auditory steady state response in free-moving rats 2020 ·PLoS ONE ·Mayako Yamazaki, (unknown), Keisuke Tamaki, Megumi Irie, Takuma Mihara	10
2	ASP2905, a specific inhibitor of the potassium channel Kv12.2 encoded by the Kcnh3 gene, is psychoactive in mice 2019 ·Behavioural Brain Research ·Shinji Takahashi, Ai Okamura, Mayako Yamazaki, Keni Ni	2
3	Synthesis, SAR study, and biological evaluation of novel 2,3-dihydro-1H-imidazo[1,2-a]benzimidazole derivatives as phosphodiesterase 10A inhibitors 2019 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), Masataka Morita, (unknown), (unknown), Y. Amano, Hiroyuki Moriguchi, Mayako Yamazaki, Masaki Aota, Masaki Tomishima, Naoyuki Masuda	6
4	Functional mechanism of ASP5736, a selective serotonin 5-HT5A receptor antagonist with potential utility for the treatment of cognitive dysfunction in schizophrenia 2018 ·European Neuropsychopharmacology ·Mayako Yamazaki, Noriyuki Yamamoto, Junko Yarimizu, Masaru Okabe, (unknown), (unknown), Monica M. Marcus, Torgny H. Svensson, Katsuya Harada	10
5	Neurochemical and neuropharmacological characterization of ASP2905, a novel potent selective inhibitor of the potassium channel KCNH3 2017 ·European Journal of Pharmacology ·Shinji Takahashi, Kohei Inamura, Junko Yarimizu, Mayako Yamazaki, Nobuhito Murai, Keni Ni	10
6	Novel benzimidazole derivatives as phosphodiesterase 10A (PDE10A) inhibitors with improved metabolic stability 2014 ·Bioorganic & Medicinal Chemistry ·(unknown), Naoyuki Masuda, Y. Amano, Kazuya Honbou, Takuma Mihara, Mayako Yamazaki, Masaki Tomishima	25
7	ASP5736, a novel 5-HT5A receptor antagonist, ameliorates positive symptoms and cognitive impairment in animal models of schizophrenia 2014 ·European Neuropsychopharmacology ·Mayako Yamazaki, Katsuya Harada, Noriyuki Yamamoto, Junko Yarimizu, Masaru Okabe, Takeshi Shimada, Keni Ni, Nobuya Matsuoka	31
8	A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease 2012 ·European Journal of Pharmacology ·Katsuya Harada, (unknown), Junko Yarimizu, Mayako Yamazaki, Masahiko Morita, Shinji Takahashi, Masaki Aota, (unknown), Hitoshi Doihara, Yuichiro Sato, Takayuki Yamaji, Keni Ni, Nobuya Matsuoka	51
9	Effects of non-steroidal anti-inflammatory drugs on Aβ deposition in Aβ1–42 transgenic C. elegans 2009 ·Brain Research ·Masahiko Morita, (unknown), Mayako Yamazaki, Fumiyuki Shirai, Nobuya Matsuoka, Hiroyuki Arakawa, Shintaro Nishimura	18
10	FK960 N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate ameliorates the memory deficits in rats through a novel mechanism of action. 1996 ·Journal of Pharmacology and Experimental Therapeutics ·Mayako Yamazaki, N. Matsuoka, Noriaki Maeda, Yasuhito Ohkubo, Isamu Yamaguchi	33
11	Brain somatostatin depletion by cysteamine attenuates the penile erection induced by serotonergic and dopaminergic, but not by cholinergic, activation in rats. 1996 ·PubMed ·Nobuya Matsuoka, Noriaki Maeda, Mayako Yamazaki, Isamu Yamaguchi	7
12	Involvement of Raphe-Hippocampal Serotonergic and Septo-Hippocampal Cholinergic Mechanisms in the Penile Erection Induced by FR121196, a Putative Cognitive Enhancer 1995 ·The Japanese Journal of Pharmacology ·Noriaki Maeda, Nobuya Matsuoka, Mayako Yamazaki, Isamu Yamaguchi	2
13	Changes in brain somatostatin in memory-deficient rats: comparison with cholinergic markers 1995 ·Neuroscience ·Naoki Matsuoka, Mayako Yamazaki, Isamu Yamaguchi	46
14	FR121196, a potential antidementia drug, ameliorates the impaired memory of rat in the Morris water maze. 1995 ·Journal of Pharmacology and Experimental Therapeutics ·Mayako Yamazaki, Naoki Matsuoka, Noriaki Maeda, (unknown), Y. Ohkubo, Isamu Yamaguchi	27
15	A Screening Concept Based on a Hypothesis Led to the Development of a Putative Cognitive Enhancer That Stimulates Penile Erection 1994 ·The Japanese Journal of Pharmacology ·Noriaki Maeda, Nobuya Matsuoka, Mayako Yamazaki, Hiroyuki Arakawa, Y. Ohkubo, Isamu Yamaguchi	9
16	Cognitive enhancing action of FR121196, a potential anti-dementia drug, and its mechanisms of action. 1994 ·The Japanese Journal of Pharmacology ·Nobuya Matsuoka, Noriaki Maeda, Mayako Yamazaki, Y. Ohkubo, Isamu Yamaguchi, Masamichi Satoh	1
17	The Possible Role of Age-Related Increase in the Plasma Glucagon/Insulin Ratio in the Enhanced Hepatic Gluconeogenesis and Hyperglycemia in Genetically Diabetic (C57BL/KsJ-db/db) Mice 1994 ·The Japanese Journal of Pharmacology ·Hiroshi Kodama, Masataka Fujita, Mayako Yamazaki, Isamu Yamaguchi	28
18	Effect of FR121196, a novel cognitive enhancer, on the memory impairment of rats in passive avoidance and radial arm maze tasks. 1992 ·Journal of Pharmacology and Experimental Therapeutics ·Naoki Matsuoka, Noriaki Maeda, Mayako Yamazaki, Y. Ohkubo, Isamu Yamaguchi	35
19	Responses to dopamine of isolated human and monkey veins compared with those of the arteries. 1991 ·Journal of Pharmacology and Experimental Therapeutics ·Tomonori Okamura, Mayako Yamazaki, Noboru Toda	12
20	Inhibition of gluconeogenesis by salicylate and 5-methoxysalicylate in liver of normal and alloxan-diabetic rats. 1986 ·PubMed ·Toshiaki Nishihata, (unknown), Mayako Yamazaki, AKIRA KAMADA	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact